Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atlas Pharmaceuticals is a U.S.-based pharmaceutical compounding company that operates as a 503B outsourcing facility serving hospitals, clinics, and other healthcare settings. The company focuses on producing sterile and non-sterile compounded medications for office or institutional use, particularly products that are unavailable, back-ordered, or customized for workflow and dosing needs. Publicly available information indicates Atlas was formed out of experience associated with Roadrunner Pharmacy and Eaton Veterinary Pharmaceuticals and built a cGMP-oriented production facility in Phoenix, Arizona. The business appears to have commercial operations rather than a traditional drug-development pipeline, and it has been described as acquired by Vets First Choice, which later became part of Covetrus. Atlas is healthcare-related, but it does not appear to be a venture-stage biotech developing novel molecular therapeutics through clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Atlas Pharmaceuticals.